Neuland Laboratories Share Price
Small Cap | Pharmaceuticals and health care | NSE: NEULANDLAB | BSE: 524558
₹10,937.60 
-481.90 (-4.22 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 11,558.65
High (₹) 11,558.65
Low (₹) 10,937.60
Prev. Close (₹) 11,419.50
Volume 887
VWAP (₹) 11,112.59
ROCE (%) 29.57
Industry P/E 43.99
TTM P/E 46.80
P/B Ratio 11.07
Market Cap (₹) Cr.14,107.10
Dividend Yield (%)0.13
EPS (₹) 233.89
ROE23.54%
Sales Growth (%) 30.84
Profit Growth (%)83.51
Day Range
11,558.6511,558.65
52 Week Range
5,532.5018,089.55
Historical Returns
Returns (6M)
-8.22 %
Returns (1Y)
56.18 %
Returns (3Y)
861.38 %
Returns (5Y)
2381.03 %
Returns (6M)
-8.22 %
Returns (1Y)
56.18 %
Returns (3Y)
861.38 %
Returns (5Y)
2381.03 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (83.52%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 83.52% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
Technicals
Technical Rating
BEARISHRSI 35.68
MFI 18.22
ATR 862.79
Commodity Channel Index -121.56
ROC125 -9.72
ROC21 -19.97
Williams %R -88.85
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 11,391.34 | 11,785.52 | 12,012.39 | 11,164.47 | 10,770.29 | 10,543.42 | 10,149.24 |
| Week Ago | 12,575.29 | 13,382.17 | 13,881.49 | 12,075.97 | 11,269.09 | 10,769.77 | 9,962.89 |
| Month Ago | 13,884.05 | 14,572.05 | 15,158.10 | 13,298.00 | 12,610.00 | 12,023.95 | 11,335.95 |
EMA & SMA
10937.60
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 11340.55
9 Day 12327.99
10 Day 12698.76
12 Day 13074.66
14 Day 13140.28
20 Day 13210.50
26 Day 13352.59
50 Day 13787.46
100 Day 14151.75
200 Day 11628.95
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| MALABAR INDIA FUND LIMITED | block | Sell | 26 Jun, 2024 | ₹7,400.00 | 1,30,000 | BSE |
| SMALLCAP WORLD FUND INC | block | Buy | 26 Jun, 2024 | ₹7,400.00 | 1,30,000 | BSE |
| MALABAR INDIA FUND LIMITED | bulk | Sell | 26 Jun, 2024 | ₹7,400.00 | 1,30,000 | BSE |
| SMALLCAP WORLD FUND INC | bulk | Buy | 26 Jun, 2024 | ₹7,400.00 | 1,30,000 | BSE |
| RAMAMOHAN RAO DAVULURI | bulk | Sell | 08 Dec, 2023 | ₹5,012.45 | 4,00,000 | BSE |
| CHARU S SHAH | bulk | Sell | 06 Aug, 2021 | ₹1,633.28 | 80,000 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 05 Dec, 2023 | Nirupama Sundar | Disposal | ₹5,375.314 | 500 | BSE |
| 24 Aug, 2023 | Davuluri Ramamohan Rao | Disposal | ₹ | 33,500 | BSE |
| 24 Aug, 2023 | Davuluri Saharsh Rao | Acquisition | ₹ | 33,500 | BSE |
| 30 Sept, 2022 | Payal Gupta | Acquisition | ₹1,278.117600631412786108918706 | 1,267 | BSE |
| 01 Sept, 2022 | Nirupama Sundar | Acquisition | ₹1,154.543333333333333333333333 | 900 | BSE |
| 22 Mar, 2022 | Davuluri Rohini Niveditha Rao | Disposal | ₹0.00001288095422108869825076641678 | 77,634 | BSE |
| 12 Feb, 2021 | GANNABATHULA VEERAVENKATA SATYANARAYANAMURTY | Disposal | ₹1,930.769230769230769230769231 | 650 | BSE |
| 12 Feb, 2021 | GANNABATHULA VENKATA KRISHNA RAMA RAO | Disposal | ₹1,950.965217391304347826086957 | 1,150 | BSE |
| 10 Feb, 2021 | SRINIVASA KRISHNA MOHAN DAVULURI | Disposal | ₹1,687.752 | 1,000 | BSE |
| 09 Feb, 2021 | GANNABATHULA VEERAVENKATA SATYANARAYANAMURTY | Disposal | ₹1,566.176470588235294117647059 | 850 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 10 May, 2024 | Rs.14.0000 per share(140%)Final Dividend | 12 Jul, 2024 | 01 Jan, 1970 |
| 11 May, 2023 | Rs.10.0000 per share(100%)Final Dividend | 11 Jul, 2023 | 01 Jan, 1970 |
| 10 May, 2022 | Rs.5.0000 per share(50%)Final Dividend | 14 Jul, 2022 | 15 Jul, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 14 Feb, 2025 | BSE India | Transcript of the Earnings call conducted on February 11, 2025 |
| 14 Feb, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about Transcript |
| 11 Feb, 2025 | BSE India | Audio Recording of the Earnings call conducted on February 11, 2025 |
| 11 Feb, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about Link of Recording |
| 11 Feb, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about Copy of Newspaper Publication |
| 10 Feb, 2025 | BSE India | Integrated Filing (Financial) for quarter and nine months ended December 31, 2024 |
| 10 Feb, 2025 | NSE India | Integrated filing (Financial) for quarter and nine months ended December 31, 2024 |
| 10 Feb, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange about Investor Presentation |
| 10 Feb, 2025 | BSE India | Investor Presentation on the Financial Results of the Company for the quarter and nine months ended December 31, 2024 |
| 10 Feb, 2025 | NSE India | Neuland Laboratories Limited has informed the Exchange regarding a press release dated February 10, 2025, titled ""Press Release on the Financial Results of the Company for the quarter and nine months ended December 31, 2024"". |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 24 Jan, 2025 | 10 Feb, 2025 |
| Quarterly Results | -- | 17 Oct, 2024 | 06 Nov, 2024 |
| Quarterly Results | -- | 19 Jul, 2024 | 01 Aug, 2024 |
| Audited Results & Final Dividend | -- | 24 Apr, 2024 | 10 May, 2024 |
| Quarterly Results | -- | 30 Jan, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 12 Oct, 2023 | 07 Nov, 2023 |
| Quarterly Results | -- | 12 Jul, 2023 | 03 Aug, 2023 |
| Audited Results & Final Dividend | -- | 18 Apr, 2023 | 11 May, 2023 |
| Quarterly Results | -- | 23 Jan, 2023 | 13 Feb, 2023 |
| Quarterly Results | -- | 20 Oct, 2022 | 10 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Neuland Laboratories
Neuland Laboratories is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1558.58 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1984
Managing Director
-- --
NSE Symbol
NEULANDLAB
Neuland Laboratories Management
| Name | Designation |
|---|---|
| Dr. Davuluri Rama Mohan Rao | Executive Chairman |
| Mr. Davuluri Sucheth Rao | Vice Chairman & CEO |
| Mr. Davuluri Saharsh Rao | Vice Chairman & Mng.Director |
| Dr. Christopher M Cimarusti | Non Executive Director |
| Dr. Nirmala Murthy | Independent Director |
| Mr. Homi Rustum Khusrokhan | Independent Director |
| Mr. Prasad Raghava Menon | Independent Director |
| Mr. Sugata Sircar | Independent Director |
| Ms. Pallavi Joshi Bakhru | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Neuland Laboratories
What is the share price of Neuland Laboratories?
The share price of Neuland Laboratories on 21 Feb, 2025 is ₹ 10,937.60.
What is 52W high and 52W low share price of Neuland Laboratories?
The highest and lowest 52W share prices of Neuland Laboratories are ₹ 18089.550 and ₹ 5029.800
What is the market cap of Neuland Laboratories?
The market capitalization of Neuland Laboratories as of 21 Feb, 2025 is ₹ 14,107.10 Crores
What is the P/E ratio of Neuland Laboratories?
The current P/E ratio of Neuland Laboratories as of 21 Feb, 2025 is 43.99
What is the PB ratio of Neuland Laboratories?
The PB ratio of Neuland Laboratories as of 21 Feb, 2025 is 11.07
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)